Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...
The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback